Semmax Financial Advisors’s AbbVie ABBV Stock Holding History

Semmax Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$102K	Sell	509 -156	-23%	-$29K	0.03%	155
2025 Q1	$124K	Buy	665 +201	+43%	+$39.1K	0.03%	138
2024 Q4	$90.5K	Sell	464 -14	-3%	-$2.57K	0.02%	143
2024 Q3	$82.6K	Sell	478 -111	-19%	-$20.7K	0.02%	135
2024 Q2	$113K	Buy	589 +146	+33%	+$24.2K	0.03%	133
2024 Q1	$72.1K	Sell	443 -78	-15%	-$13.4K	0.02%	138
2023 Q4	$91.1K	Buy	521 +100	+24%	+$14.6K	0.03%	126
2023 Q3	$58.9K	Buy	+421	New	+$61.8K	0.02%	115
2022 Q4	–	Sell	-37	Closed	-$6K	–	280
2022 Q3	$6K	Hold	37	–	–	﹤0.01%	178
2022 Q2	$5K	Buy	37 +1	+3%	+$153	﹤0.01%	189
2022 Q1	$6K	Hold	36	–	–	﹤0.01%	205
2021 Q4	$5K	Buy	+36	New	+$4.25K	﹤0.01%	204
2020 Q4	–	Sell	-1	Closed	–	–	238
2020 Q3	$0	Buy	+1	New	+$94	﹤0.01%	243
2019 Q2	–	Sell	-3,273	Closed	-$264K	–	343
2019 Q1	$264K	Sell	3,273 -7,112	-68%	-$582K	0.18%	114
2018 Q4	$957K	Buy	+10,385	New	+$913K	0.75%	33

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Semmax Financial Advisors's ABBV Position: Q2 2025 in Review

Semmax Financial Advisors reduced its AbbVie (ABBV) stake by 23% in Q2 2025, selling an estimated $29K and leaving 509 shares worth $102K. The position accounts for 0.03% of the portfolio, ranked #155.

Semmax Financial Advisors first reported a position in ABBV in Q4 2018 and has held it in 15 quarters since. The position peaked at $957K in Q4 2018. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Semmax Financial Advisors held 509 shares of AbbVie worth $102K as of Q2 2025.
Semmax Financial Advisors sold 156 AbbVie shares in Q2 2025, an estimated $29K.
AbbVie made up 0.03% of Semmax Financial Advisors's portfolio in Q2 2025, its #155 holding.
Semmax Financial Advisors first reported a position in AbbVie in Q4 2018 and has held it in 15 quarters since.
Semmax Financial Advisors's AbbVie position peaked at $957K in Q4 2018.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Semmax Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.